Directory
>
Demetrios Braddock
Demetrios Braddock
Scientific Founder | Inozyme Pharma
New Haven, Connecticut, United States
Demetrios Braddock
Summary
Demetrios Braddock is an accomplished hematopathologist and biochemist with a strong focus on rare diseases, particularly those affecting children. As an Associate Professor at Yale University and Scientific Founder of Inozyme Pharma, he leads innovative research aimed at uncovering disease mechanisms and developing novel therapeutic strategies. His expertise spans across multiple domains of pathology and biochemistry, underpinned by extensive experience in clinical and translational research. Demetrios has a proven track record in establishing and guiding scientific initiatives within start-up environments, showcasing his entrepreneurial spirit. His work is characterized by a commitment to improving patient outcomes through rigorous scientific inquiry and collaboration. He is not just a researcher but also an advocate for addressing overlooked medical challenges, making significant contributions to the field of oncology and rare diseases.
Demetrios Braddock
Work Experience
Scientific Founder at
Inozyme Pharma
January 2017 - Present
Associate Professor of Pathology at
Yale University Press
January 2004 - Present
Associate Professor at
Yale University-
January 2004 - Present
Medical Director at
Precipio Diagnostic
June 2011 - November 2017
Senior Regulatory Research Supervisor at
FDA
December 2002 - October 2003
Research Associate at
The National Institutes of Health
July 2000 - December 2002
Clinical Fellow at
National Cancer Institute (NCI)
January 1996 - January 2000
Demetrios Braddock
Education
The University of Chicago Pritzker School of Medicine, Md/Phd
January 1988 - January 1996
University of Chicago, Ba
January 1984 - January 1988
Frequently Asked Questions about Demetrios Braddock
What is Demetrios Braddock email address?
Demetrios Braddock's primary email address is ******************@inozyme.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Demetrios Braddock work for?
Demetrios Braddock is a Scientific Founder at Inozyme Pharma, a company specializing in Commercial physical research.
Where Demetrios Braddock graduated from?
Demetrios Braddock holds a degree in Biochemistry And Medicine from The University of Chicago Pritzker School of Medicine.
How can I directly contact Demetrios Braddock?
To contact Demetrios Braddock directly, you can use the email address ******************@inozyme.com. Complete contact information is available upon registration with Muraena.
Who is Demetrios Braddock?
Demetrios Braddock is an accomplished hematopathologist and biochemist with a strong focus on rare diseases, particularly those affecting children. As an Associate Professor at Yale University and Scientific Founder of Inozyme Pharma, he leads innovative research aimed at uncovering disease mechanisms and developing novel therapeutic strategies. His expertise spans across multiple domains of pathology and biochemistry, underpinned by extensive experience in clinical and translational research. Demetrios has a proven track record in establishing and guiding scientific initiatives within start-up environments, showcasing his entrepreneurial spirit. His work is characterized by a commitment to improving patient outcomes through rigorous scientific inquiry and collaboration. He is not just a researcher but also an advocate for addressing overlooked medical challenges, making significant contributions to the field of oncology and rare diseases.
Demetrios`s contact details
******************@inozyme.com
******************@yale.edu
*****@email.med.yale.edu
Colleagues
Chief Financial Officer
Vice President Information Technology
SVP | Chief Technical Operations Officer
Vice President Worldwide Clinical Operations & Site Strategy
SVP & Chief People Officer
SVP and Chief Medical Officer
Vice President, Head of Program Management
Chief Executive Officer And Chairman
Vice President, Toxicology
Vice President, Regulatory Affairs, Medical Writing, and Pharmacovigilance